𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Difference in prevalence of human papillomavirus genotypes in cytomorphologically normal cervical smears is associated with a history of cervical intraepithelial neoplasia

✍ Scribed by Adriaan J. C. Van Den Brule; Jan M. M. Walboomers; Marc Du Maine; Peter Kenemans; Chris J. L. M. Meijer


Publisher
John Wiley and Sons
Year
1991
Tongue
French
Weight
584 KB
Volume
48
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


The prevalence of human papillomavirus (HPV) genotypes was investigated by the polymerase chain reaction (PCR) method in cytologically normal and abnormal cervical scrapes obtained from asymptomatic women (n = I ,346), participating in a triennial screening program for cervical cancer, and from a gynecological outpatient population (n = 593). In the symptom-free population oncogenic HPV types 16, 18,31 and 33 were present in I .5% of cytologically normal scrapes, while the overall HPV prevalence rate was 3.5%. Significantly, higher HPV prevalence rates of 7% (oncogenic HPV; p .-: 0.01) and 14% (all HPV; p O.Ol), respectively, were found in cytologically normal scrapes of the gynecologic outpatient population. It appeared that in this outpatient group 78% of the smears containing HPV I 6 and I 8 were associated with a history of cervical pathology, i.e. cervical intraepithelial neoplaria grade I to Ill. In smears with mild and severe dysplasia and smears suspected of carcinoma in situ from both populations, the overall HPV prevalence was 70%. 84% and 100%. respectively. In all squamous-cell carcinomas of the cervix (n = 50) HPV was detected. Frequencies of HPV 16 and 18 increased from 41% in mild dysplasia to 94% in cervical carcinomas. Since a low prevalence of HPV was found in cytomorphologically normal cervices of women without a clinicopathological history, the findings in this study suggest that HPV detection in population-based screening programs for cervical neoplasia can be an important tool in identifying women who are at risk of developing dysplasia and cervical cancer. KOPAC classification, briefly: Pap I, normal cells; Pap 11, inflammation; Pap III", mild and moderate dysplasia; Pap HIb, 3To whom correspondence and reprint requests should be addressed.


πŸ“œ SIMILAR VOLUMES


Genotyping of human papillomavirus in ce
✍ Carmen G. Ili; Priscilla Brebi; Jaime LΓ³pez; Patricia GarcΓ­a; Pamela Leal; Eugen πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 69 KB πŸ‘ 2 views

## Abstract Infection with the human papillomavirus (HPV) is responsible for 99.7% of cervical cancers, the second most prevalent neoplasia in women worldwide and the fifth leading cause of death by cancer in this population. In Chile, the incidence rate is 14.4 cases per 100,000 women per year and

Prevalence of human papillomavirus genot
✍ Iain J. MacLeod; Belinda O'Donnell; Sikhulile Moyo; Shahin Lockman; Roger L. Sha πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 250 KB

## Abstract Human papillomaviruses (HPV) constitute one of the most prevalent sexually transmitted infections and are the etiological agents for invasive cervical cancer, the predominant cancer among women in Botswana. However, the prevalence of HPV genotypes in Botswana has yet to be reported. On

Human papillomavirus DNA after treatment
✍ Liesbeth J. M. Bollen; Steven P. Tjong-A-Hung; Jacobus van der Velden; Ben W. J. πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 522 KB

## BACKGROUND. The presence of human papillomavirus (HPV) DNA in relation to cervical cytology was evaluated after treatment of cervical dysplasia. METHODS. Forty patients, 22 with normal and 18 with abnormal cytology (mild or moderate dyskaryosis), with a history of cervical dysplasia were selecte

Human papillomavirus genotypes and their
✍ Brian Brestovac; Gerry B. Harnett; David W. Smith; Geoffrey R. Shellam; Felicity πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 73 KB πŸ‘ 1 views

Human papillomavirus (HPV) is known to be the cause of almost all cervical cancers. The genotypes have been classified into high and low risk types according to their oncogenic potential. However, data for many of the genotypes are limited and some (HPV-26, 53, and 66) have no agreed status. A study

Typing of human papillomavirus in women
✍ Maria Teresa Sandri; Daniela Riggio; Michela Salvatici; Rita Passerini; Laura Zo πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 107 KB

## Abstract Human papillomavirus (HPV) are distributed widely and persistent infection with high‐risk (HR) HPV is recognized as a necessary cause of cervical cancer. The aim of this study was to evaluate the distribution of different HR‐HPV genotypes in 199 women with cervical pre‐invasive lesions

Prevalence of types 16 and 33 is increas
✍ Nicole W.J. Bulkmans; Maaike C.G. Bleeker; Johannes Berkhof; Feja J. Voorhorst; πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 82 KB πŸ‘ 2 views

## Abstract High‐risk human papillomavirus (hrHPV) types are causally related to cervical cancer and its high‐grade precursor lesions. The risk posed by the different hrHPV types for the development of cervical intraepithelial neoplasia grade 2 or worse (β‰₯CIN2) needs to be established. Here, we pre